Skip to content
Screener

Total Equity at other companies

3M logo
3MMMM
$2.95B-31.2%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$714.56M+9.0%
Biogen logo
BiogenBIIB
$18.85B+6.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$614.86M+83.4%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$14.04B-38.5%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$21.04M-122%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemJune 30, 2026December 31, 2025
Commitments and contingencies (Note 9)
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 17.9 and 17.8 shares issued and outstanding17.917.8
Additional paid-in capital106.3105.7
Retained earnings1,137.41,119.3
Accumulated other comprehensive loss(56.9)(47.1)
Total shareholders' equity1,204.71,195.7
Total liabilities and shareholders' equity$1,446.4$1,429.9

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's total equity?
Rogers Corporation (ROG) reported total equity of $1.2B in Q2 2026.
How has Rogers Corporation's total equity changed year-over-year?
Rogers Corporation's total equity decreased by 0.2% year-over-year, from $1.21B to $1.2B.
What is the long-term trend for Rogers Corporation's total equity?
Over 5 years (2020 to 2025), Rogers Corporation's total equity has grown at a 3.2% compound annual growth rate (CAGR), from $1.02B to $1.2B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Rogers Corporation's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude